Gain Insights Into Therapeutic Resistance With Single Cell RNA-Seq
Single cell RNA sequencing (scRNA-seq) provides the resolution and scale to unravel the complexity of cancer biology and reveal insights to advance human health. Join Dr. Allison Stewart and Dr. Carl Gay of MD Anderson Cancer Center as they discuss using scRNA-seq to discover intratumoral transcriptional profiles that emerge during resistance to targeted therapies. Their work alludes to new hypotheses around how therapies might be deployed in combination to minimize resistance.
Watch this webinar to hear how researchers use scRNA-seq to:
- Analyze patient-derived CDX models and circulating tumor cells
- Monitor intratumoral heterogeneity (ITH) during a longitudinal study
- Develop a working model for combinational therapeutics to delay development of ITH
